As of the close on January 29, 2024, Antisense Therapeutics Limited's stock has declined approximately 36.36% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.06.
| 52-Week Price Change | -36.36% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.06 |
Antisense Therapeutics Limited's most recent stock split took place on November 6, 2013 with a 10:1 split ratio.
| Last Split Date | 11/6/2013 |
| Split Ratio | 10:1 |
Already premium?